Note Twelve — Loss Per Share

The following table presents the loss per share calculation for the periods presented:

	Quarter Ended						Six Months Ended
(In millions)	June 30, 2018			June 30, 2017			June 30, 2018			June 30, 2017
Net loss	$	(4.5	)	$	(6.8	)	$	(6.7	)	$	(11.7	)
Dividends related to 7% Series B convertible preferred stock⁽¹⁾		(0.2	)		(0.1	)		(0.3	)		(0.3	)
Net loss available to common stockholders	$	(4.7	)	$	(6.9	)	$	(7.0	)	$	(12.0	)
Per share of common stock:
Basic/diluted net loss available to common stockholders	$	(0.15	)	$	(0.22	)	$	(0.22	)	$	(0.41	)
(In thousands)
Weighted average shares outstanding (basic and diluted)		31,927			31,336			31,837			29,379
Anti-dilutive common stock equivalents⁽²⁾		1,481			1,120			1,487			1,660

(1)

Dividends on 7% Series B convertible preferred stock (Series B stock) are cumulative and have been accrued from July 1, 2012 to June 30, 2018. Total accrued dividends were $3.5 million as of June 30, 2018. Dividends will continue to accrue until they are declared by the company’s board of directors. The company has not declared any dividends with respect to the Series B stock in 2018 or 2017.

(2)	In periods in which there was a loss, the effect of common stock equivalents, which is primarily related to the Series B stock, was not included in the diluted loss per share calculation as it was antidilutive.